Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
As you choose to be for or against Dr. Alfred Mann consider the following;
Alfred Mann has stated that Afrezza could be the biggest selling drug in history.
Consider the following throughout history 99.5% of the population has an I.Q. of less than 140:
Einstein - 160
Bill Gates - 160
Stephen Hawking - 160
Alfred Mann - 172
Galileo - 185
Sir Issac Newton - 190
Leonardo Da Vinci - 220
Choose your side carefully! I know where I'm putting my money, and that is not with Cramer, AF. or the rest of the shorts.
We will never go back!! Afrezza + Google = a new paradigm shift.
This just the beginning of being able to have realtime control of BG. The cat is out of the bag as we use technology to manage and change. No one ever wants to go back on technology; do you want to use a typewriter? Ever think about going back to the computer before there was a mouse? How about the iPhone vs the flip phone? The demand for this technology is exceeding supply. Google will spend millions, (or already has), to make monitoring as easy as checking a text, and Afrezza will be there to lead the way to managed control. Afrezza is the real deal Crew.
Aloha Crew: Wow! Checkout this TV 10 news story on Afrezza that ran in Miami today. It's great! Little by little, we are on our way. Go MNKD! http://www.local10.com/news/health/new-form-of-insulin-helps-some-diabetes-patients-manage-disease/36238950
Question: if someone claims they hold no position in MNKD, but are naked shorting the stock, then technically they still own no shares cuz they are phantom? Is that correct to state?
When you're dealing with disruptive technologies, you have to consider that it can change industries and write a new rulebook. Those BP who embrace it stand to make $billions while other companies fade into history.
Much depends on how well Afrezza performs in terms of market acceptance, and early indications are extremely positive. Aloha.
Imagine the synergy of "smart contact lens" (from Google Life) to monitor glucose without the "finger pricks."
Combined with OUR Afrezza which "flat lines" blood glucose levels with near perfect predictability without injections and add the best of class basal from SNY and you have the potential for a worldwide diabetes market monopoly.
Google Life Sciences is committed to health care and in particular, diabetes.
MNKD can bring IMMEDIATE delivery of revolutionary technologies vs. years of expensive R&D for Google to test fly unknown innovations they would have to "discover", test, validate, and wiggle thru the FDA, with NO
guarantees.
There are many other forces driving up the lending rate, of much more significance, than what has been mentioned here. Aloha.
Well Goose, even those the Longs may not agree with, are allowed to post here. Let em have it if you don't agree cuz you can post too! Aloha.
Sales numbers speak, and in the long run it is sales that count. Aloha.
Some very good detective from another board. Check this out:
It’s always beneficial to know the context (motive) of who is behind the words.
I clicked on the author link for Motley Fools latest MNKD trash piece, “3 Popular Stocks That Have Us Spooked.” This is authored by Brian Feroldi
www.fool.com/investing/general/2015/10/31/3-popular-stocks-that-have-us-spooked.aspx?source=eogyholnk0000001&utm_source=yahoo&utm_medium=feed&utm_campaign=article
In his Bio – Personal Quote, he quotes the philosopher Diogenes. Some of you may know of the anonymous hack that writes Afrezza scrip update pieces for Seeking Alpha. The one who takes facts and launches into wildly negative speculations about the implications for MNKD is known as Looking for Diogenes.
seekingalpha.com/article/3599246-mannkind-weekly-data-updatesminus-10-16-15-data
For me, the coincidence is enough evidence to believe the authors are connected and/or the same person. Obscure philosopher references + repeated vendetta MNKD trash articles = Bingo. My assumption is supported by the note in Mr Feroldi’s employment history as having been a Territory Manager for Insulet. Don’t they make an inferior pump to the one Al invented, developed and sold to Medtronic? Maybe Mr. Feroldi is looking to even the score & find someone to blame for his failure selling insulin pumps and now finding that his lot in life is to write disingenuous tripe for a dishonest employer.
I wonder if he uses an alias for cover in his Seeking Alpha “work” because writing there is in conflict with his contract at Motley Fool?
Read more: http://mnkd.proboards.com/thread/3915/unmasking-seeking-alpha-hack?page=1#ixzz3qOpniRzI
I saw this elsewhere and was highly impressed. Good thing Al has great genes and can/will keep on ticking. We're gonna need him around for awhile longer yet! Aloha.
You got that right Cave. The battle rages on! Go MNKD. Aloha.
I like that Robert: "ignore the FUD, follow the pros." I also like following Dr. Alfred Mann; A billionaire with a trail of business success behind him, and deep pockets! Aloha.
Yeah, I stopped clicking on all the FUD posts here sometime back. What's the point of reading any of them. Anyhoo, I suspect we may see reaffirmation of Sanofi's intent with Afrezza on the 6th. That would be nice, and hopefully we'll see a script bump on the same day. Aloha.
Try not to let the FUD get to you Y47, is all I can say. GLTY.
Expectations: If I had been expecting a very slow start, with perhaps a year before script traction, then the weekly script counts would be satisfying. I must reset my expectations to be in line with the realities that Afrezza is facing. There are numerous headwinds that will take time to overcome.
These include; insurance coverage, doctor education, tier 2 coverage, patient education and advertising. Its going to take time. Aloha.
That was a brilliant move by McDonalds. Smart CEO's everywhere just like Dr. Al Mann, who brought us Alfrezza, all day, all the time!
It's inevitable of the profoundly positive impact Afrezza will have in the world of diabetes therapies. Once Afrezza's absorption kinetics are understood by healthcare providers and patients, Afrezza will become the new “normal science” for treating diabetes.
Afrezza will overtake basal insulin as the first course of insulin therapy for type 2 diabetics beginning insulin therapy, (earlier in the treatment plan), and will replace existing RAA options for a majority of patients already on prandial insulin.
When this happens, not only will Afrezza reach “mega-blockbuster” status but it could become the most valuable drug of our time. The Paradigm Shift of Afrezza is inevitable -- improving the health and Quality of Life for millions of diabetics. It's going to be beautiful Crew!
PPS manipulation, debt, and cash flow? Be as ascerbic as you like, what is the worst case? How much longer can they operate? 6 months? 1 year? 2 years? 3 years? If your company has material cash flow from lots of customers, and has any reasonable chance of bouncing back and paying on debt, there are lots of greedy folks who are willing to hand you increasingly expensive capital; what Adam Fuerstein calls "death sprial financing" from his goofy "article" last summer.
Are we already there? Is the recent $100M note re-finance an example? Meh. I'm not an expert in corporate finance, but I don't think that it is; AF's doom-and-gloom hit piece notwithstanding.
So where are we? PPS depressed, but not without hope; a strong, global, partner, a solvent corporation, and sales with customer retention which are durable and improving! Time for more peanuts beer, Mai Tais on this NFL Sunday Crew, where my Packers will win big! Aloha.
There have been challenges and headwinds, but Afrezza just continues to deliver. What fundamentally is going to stop that? Extreme side-effects of Afrezza after years of trials and 6,000 patients? Very low liklihood of that.
What then?
Big bad bio pharma playing PPS tricks? Sanofi IS big bad bio pharma. Nobody should seriously doubt their commitment to their $1B contract with Mannkind Corp. Maybe before the $200M (or is it up to $225M now?) in milestone payments, it was titillating to consider Machevellian corporate drama, but now after ADA conference, initiation of DTC, sales conference training, and a durable sales results, should a serious investor cling to doubts?
Afrezza is going to win, and win big!
As evidenced in the social media arena, Afrezza works, and works extremely well! In fact, many have described Afrezza as a paradigm shift in diabetic treatment. It appears that once a patient changes to Afrezza they will not be changing back. Therefore, that steady script number will not change for any reason, except to go up, like it did last Friday.
Diabetics need to control their disease in all seasons; a good economy or bad economy, until there is a cure. That kind of consistency in the blockbuster drug Afrezza, will make Mannkind stock very valuable indeed! Aloha.
They huffed, puffed, they called out the corrupt press, they borrowed and threw shares, and they called out their minions to come here and try to change the mood. What an effort!
However, the stock price is still higher than it was a month ago. The old tactics that Wall Street weasels have used since the great depression, seem not to be working as well in the age of the internet. No one spends this kind of time and money trying to kill a supposedly "bad" stock unless they are deathly afraid of what Afrezza can do. It's really that simple, but sure doesn't seen that way at times!
It's a game changer Crew, and social media is keeping it all alive for us until the big guns of the DTC are unleashed by Sanofi, and when they are, the Shorts and detractors here will run for the hills. You can take that to the bank Crew. Aloha.
Aloha Crew: Incredible. These articles, (7!!), all came out since 10/23. IMO, these articles are all biased against MNKD, but I will let you be the judge. What are they so afraid of Crew?
Another Month, Another Crushing Decline for MNKD
3 Popular Stocks That Have Us Spooked
Nil Revenues, Negative Cash Flows, And Huge Accumulated Deficit - A Long Way To Go
MNKD Stock: A Cloud Hangs Over Q3
All Eyes On Mankind Ahead Of Q3 Earnings Report
Mannkind Afrezza Sales Flop Again. Sanofi Losing Patience
Mannkind Weekly Date Updates 10/23/15
Aloha Hypi: Nice outline and yes, M & Afrezza are here to stay. What a drug...total game changer!
Once Afrezza catches on, there will be no stopping it. BP, GS, PJ, Cramer, (his tool; AF & others), The Street, Motley Fool, SA, the Shorts, all know this.
They want to kill Afrezza in the crib, but guess what? Thanks to social media that just isn't going to happen. Once Sanofi launches its big guns in the DTC, its game over for all them, and they know that too.
This may take time, and more bumps are ahead, but in the end Afrezza is that game changer, and we will profit from it. Go MNKD!
I know, it's ridiculous the FUD here. Lions & Tigers & Shorts, oh my! Happy Halloween All!
I have been, and will continue to be concerned about this stock.
However I bend but don't break, and know that this may be a slow long climb to the top, but it will happen. MNKD will open in Europe, and worldwide eventually and be a huge success. The product has too good results not to succeed. People are extremely satiisfied with Afrezza and it will take time, but will succeed. Shorts will eventually cover and that Crew, is all there is to it. Aloha.
You're certainly entitled to your opinion here, although I still disagree. Aloha.
Meaning no disrespect, but why? Q is in no position to do an uplisting at this time. And, IMO doing a R/S would be a huge mistake. Why even discuss such a radical action that almost always hurts the shareholder in a big way? I'm out the door fast and completely if there's any hint of a R/S occurring. (which I suppose would make some here quite happy).
Please, let's get some real sales, a real contract, going before discussing anything else! Aloha.
This will pass. Sales will determine our fate!
Aloha Purdue: No, I stopped reading AF's trash-talk articles sometime ago, as I hope many others have too. The lad has 0 credibility with me at least, and I haven't heard of any serious side effects, from the growing population of users.
Aloha Crew: Weekly prescription numbers released by Symphony and IMS today show a nice jump. I anticipate soon, there will be a sudden and sizable increase in numbers that will get people’s attention, and change the tone and game of the conversation in a significant manner. Shorts are petrified of increasing script counts. Take it the bank Ladies & Gents. Hold onto your shares!
Ex: Nobody except shorts read AF trash talk articles anymore.
I noticed SA just came out with a new hit piece on MNKD. They are pulling out all the stops. They are determined to try and bring MNKD down. What are they so afraid of Crew? Aloha.
Aloha Dock! Go QMC. Drink one, smoke one!
No surprises there Ty!! Let's hope we're past this short attack. Mahalo for pointing that out.
Nice moves Coo! Many here, including me, wish we had an entry point that low. Good for you. Aloha.
That's excellent advice Robert. Mahalo for resharing this article with us! Aloha.
Ha, those cheap shares earlier today were a Goddess send! Aloha.
That was pretty much it King, then the AF hit piece came out today. FUD spreaders everywhere now pulling out all the stops to try and drive down the SP. Hang tough. Aloha.
Aloha Crew: Nice bear raid underway, timed perfectly with the AF hit piece and no ringing endorsement from Sanfoi today. However, we are already climbing back. Hang in there! Cheers.